Literature DB >> 24350640

Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: is lobectomy sufficient for tumours ≥1 cm?

Pedro Weslley Rosario1, Gustavo Cancela Penna, Maria Regina Calsolari.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24350640     DOI： 10.1111/cen.12387

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  19 in total

1.  Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant.

Authors:  Ian Ganly; Laura Wang; R Michael Tuttle; Nora Katabi; Gustavo A Ceballos; H Ruben Harach; Ronald Ghossein
Journal:  Hum Pathol       Date:  2015-02-04       Impact factor: 3.466

Review 2.  Encapsulated Thyroid Carcinoma of Follicular Cell Origin.

Authors:  Bin Xu; Ronald Ghossein
Journal:  Endocr Pathol       Date:  2015-09       Impact factor: 3.943

3.  Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

4.  Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.

Authors:  Marco Raffaelli; Carmela De Crea; Luca Sessa; Guido Fadda; Celestino Pio Lombardi; Rocco Bellantone
Journal:  Endocrine       Date:  2018-05-16       Impact factor: 3.633

5.  Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in children and adolescents.

Authors:  Pedro Weslley Rosario; Grabriela Franco Mourão
Journal:  Endocrine       Date:  2018-07-04       Impact factor: 3.633

6.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Authors:  Yuri E Nikiforov; Raja R Seethala; Giovanni Tallini; Zubair W Baloch; Fulvio Basolo; Lester D R Thompson; Justine A Barletta; Bruce M Wenig; Abir Al Ghuzlan; Kennichi Kakudo; Thomas J Giordano; Venancio A Alves; Elham Khanafshar; Sylvia L Asa; Adel K El-Naggar; William E Gooding; Steven P Hodak; Ricardo V Lloyd; Guy Maytal; Ozgur Mete; Marina N Nikiforova; Vania Nosé; Mauro Papotti; David N Poller; Peter M Sadow; Arthur S Tischler; R Michael Tuttle; Kathryn B Wall; Virginia A LiVolsi; Gregory W Randolph; Ronald A Ghossein
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

7.  Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?

Authors:  Bin Xu; Nada Farhat; Justine A Barletta; Yin P Hung; Dario de Biase; Gian Piero Casadei; Ayse Mine Onenerk; R Michael Tuttle; Benjamin R Roman; Nora Katabi; Vania Nosé; Peter Sadow; Giovanni Tallini; William C Faquin; Ronald Ghossein
Journal:  Endocrine       Date:  2017-12-04       Impact factor: 3.633

8.  Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapy.

Authors:  Marina S Carvalho; Pedro W Rosario; Gabriela F Mourão; Maria R Calsolari
Journal:  Endocrine       Date:  2016-11-23       Impact factor: 3.633

Review 9.  Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists.

Authors:  Raja R Seethala; Zubair W Baloch; Justine A Barletta; Elham Khanafshar; Ozgur Mete; Peter M Sadow; Virginia A LiVolsi; Yuri E Nikiforov; Giovanni Tallini; Lester Dr Thompson
Journal:  Mod Pathol       Date:  2017-10-20       Impact factor: 7.842

Review 10.  Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Historical Context, Diagnosis, and Future Challenges.

Authors:  Bin Xu; Giovanni Tallini; Ronald A Ghossein
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.